Table of Content

1 EXECUTIVE SUMMARY


2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 MARKET STRUCTURE

2.4 ASSUMPTIONS & LIMITATIONS


3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION


4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING PREVALENCE OF EPILEPSY AND DEMAND FOR SURGICAL PROCEDURES

4.2.2 RISING NUMBER OF CASES OF BRAIN INJURIES DUE TO ROAD ACCIDENTS

4.2.3 ADVANCEMENT AND ADOPTION OF ROBOT-ASSISTED SURGERY

4.3 RESTRAINT

4.3.1 STRINGENT GOVERNMENT REGULATIONS AND COMPLICATIONS ASSOCIATED WITH SURGERY

4.4 OPPORTUNITY

4.4.1 COLLABORATION WITH RESEARCH INSTITUTES FOR MARKET ENTRANTS TO ACCESS GLOBAL MARKETS


5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION

5.1.4 MARKETING & SALES

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 BARGAINING POWER OF BUYERS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF NEW ENTRANTS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON DEMAND

5.3.3 AVAILABILITY AND ACCESS TO HEALTHCARE FACILITIES

5.3.4 IMPACT ON REVENUE AND STRATEGIC DECISIONS BY COMPANIES


6 GLOBAL EPILEPSY SURGERY MARKET BY PROCEDURE TYPE

6.1 OVERVIEW

6.2 RESECTIVE SURGERY

6.3 LASER INTERSTITIAL THERMAL THERAPY (LITT)

6.4 OTHERS


7 GLOBAL EPILEPSY SURGERY MARKET BY END USER

7.1 OVERVIEW

7.2 HOSPITALS & CLINICS

7.3 SPECIALTY CENTERS

7.4 OTHERS


8 GLOBAL EPILEPSY SURGERY MARKET, BY REGION

8.1 OVERVIEW

8.2 AMERICAS

8.2.1 NORTH AMERICA

8.2.1.1 US

8.2.1.2 CANADA

8.2.2 LATIN AMERICA

8.3 EUROPE

8.3.1 WESTERN EUROPE

8.3.1.1 GERMANY

8.3.1.2 UK

8.3.1.3 FRANCE

8.3.1.4 ITALY

8.3.1.5 SPAIN

8.3.1.6 REST OF WESTERN EUROPE

8.3.2 EASTERN EUROPE

8.4 ASIA PACIFIC

8.4.1 CHINA

8.4.2 JAPAN

8.4.3 INDIA

8.4.4 SOUTH KOREA

8.4.5 AUSTRALIA

8.4.6 REST OF ASIA PACIFIC

8.5 MIDDLE EAST & AFRICA

8.5.1 MIDDLE EAST

8.5.2 AFRICA


9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW

9.2 COMPETITIVE BENCHMARKING

9.3 MAJOR GROWTH STRATEGY IN THE GLOBAL EPILEPSY SURGERY MARKET

9.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL EPILEPSY SURGERY MARKET

9.5 KEY DEVELOPMENT ANALYSIS

9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

9.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL

9.6.2 MERGER/ACQUISITION

9.7 FINANCIAL MATRIX

9.7.1 SALES (USD MILLION), 2020

9.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2020


10 COMPANY PROFILES

10.1 STRYKER

10.1.1 COMPANY OVERVIEW

10.1.2 FINANCIAL OVERVIEW

10.1.3 PRODUCTS/SERVICES OFFERED

10.1.4 KEY DEVELOPMENTS

10.1.5 SWOT ANALYSIS

10.1.6 KEY STRATEGIES

10.2 ZIMMER BIOMET HOLDINGS INC.

10.2.1 COMPANY OVERVIEWS

10.2.2 FINANCIAL OVERVIEW

10.2.3 PRODUCTS/SERVICES OFFERED

10.2.4 KEY DEVELOPMENTS

10.2.5 SWOT ANALYSIS

10.2.6 KEY STRATEGIES

10.3 AURIS HEALTH, INC. (HANSEN MEDICAL, INC.)

10.3.1 COMPANY OVERVIEW

10.3.2 FINANCIAL OVERVIEW

10.3.3 PRODUCTS/SERVICES OFFERED

10.3.4 KEY DEVELOPMENTS

10.3.5 SWOT ANALYSIS

10.3.6 KEY STRATEGIES

10.4 INTUITIVE SURGICAL

10.4.1 COMPANY OVERVIEW

10.4.2 FINANCIAL OVERVIEW

10.4.3 PRODUCTS/SERVICES OFFERED

10.4.4 KEY DEVELOPMENTS

10.4.5 SWOT ANALYSIS

10.4.6 KEY STRATEGIES

10.5 MEDTRONIC PLC (MAZOR ROBOTICS)

10.5.1 COMPANY OVERVIEW

10.5.2 FINANCIAL OVERVIEW

10.5.3 PRODUCTS/SERVICES OFFERED

10.5.4 KEY DEVELOPMENTS

10.5.5 SWOT ANALYSIS

10.5.6 KEY STRATEGIES

10.6.4 KEY DEVELOPMENTS

10.7 CMR SURGICAL

10.7.1 COMPANY OVERVIEW

10.7.2 FINANCIAL OVERVIEW

10.7.3 PRODUCTS/SERVICES OFFERED

10.7.4 KEY DEVELOPMENTS

10.7.5 SWOT ANALYSIS

10.7.6 KEY STRATEGIES

10.8 NATUS MEDICAL INCORPORATED

10.8.1 COMPANY OVERVIEW

10.8.2 FINANCIAL OVERVIEW

10.8.3 PRODUCTS OFFERED

10.8.4 KEY DEVELOPMENTS

10.8.5 SWOT ANALYSIS

10.8.6 KEY STRATEGIES

10.9 LIVANOVA PLC

10.9.1 COMPANY OVERVIEW

10.9.2 FINANCIAL OVERVIEW

10.9.3 PRODUCTS OFFERED

10.9.4 KEY DEVELOPMENTS

10.9.5 SWOT ANALYSIS

10.9.6 KEY STRATEGIES

10.10 MONTERIS MEDICAL

10.10.1 COMPANY OVERVIEW

10.10.2 FINANCIAL OVERVIEW

10.10.3 PRODUCTS/SERVICES OFFERED

10.10.4 KEY DEVELOPMENTS

10.10.5 SWOT ANALYSIS

10.10.6 KEY STRATEGIES

11 APPENDIX

11.1 REFERENCES

11.2 RELATED REPORTS

?



List of Figures

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 MARKET STRUCTURE: GLOBAL EPILEPSY SURGERY MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: GLOBAL EPILEPSY SURGERY MARKET

FIGURE 5 DRIVERS: IMPACT ANALYSIS

FIGURE 6 RESTRAINT: IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN: GLOBAL EPILEPSY SURGERY MARKET

FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: GLOBAL EPILEPSY SURGERY MARKET

FIGURE 9 GLOBAL EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2020 & 2027 (USD MILLION)

FIGURE 10 GLOBAL EPILEPSY SURGERY MARKET, BY END USER, 2020 & 2027 (USD MILLION)

FIGURE 11 GLOBAL: EPILEPSY SURGERY MARKET, BY REGION 2020 & 2027 (USD MILLION)

FIGURE 12 GLOBAL: EPILEPSY SURGERY MARKET SHARE (%), BY REGION, 2020

FIGURE 13 AMERICAS: EPILEPSY SURGERY MARKET SHARE (%), BY REGION, 2020

FIGURE 14 NORTH AMERICA: EPILEPSY SURGERY MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 15 EUROPE: EPILEPSY SURGERY MARKET SHARE (%), BY REGION, 2020

FIGURE 16 WESTERN EUROPE: EPILEPSY SURGERY MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 17 ASIA PACIFIC: EPILEPSY SURGERY MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 18 MIDDLE EAST & AFRICA: EPILEPSY SURGERY MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 20 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL EPILEPSY SURGERY MARKET

FIGURE 21 GLOBAL EPILEPSY SURGERY MARKET: COMPETITIVE LANDSCAPE

FIGURE 22 SALES (USD MILLION), 2020

FIGURE 23 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2020

FIGURE 24 STRYKER: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 STRYKER: SWOT ANALYSIS

FIGURE 26 ZIMMER BIOMET HOLDINGS INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 ZIMMER BIOMET HOLDINGS INC.: SWOT ANALYSIS

FIGURE 28 AURIS HEALTH, INC. (HANSEN MEDICAL, INC.): SWOT ANALYSIS

FIGURE 29 INTUITIVE SURGICAL: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 INTUITIVE SURGICAL: SWOT ANALYSIS

FIGURE 31 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 MEDTRONIC PLC: SWOT ANALYSIS

FIGURE 34 CMR SURGICAL: SWOT ANALYSIS

FIGURE 35 NATUS MEDICAL INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 36 NATUS MEDICAL INCORPORATED: SWOT ANALYSIS

FIGURE 37 LIVANOVA PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 38 LIVANOVA PLC: SWOT ANALYSIS

FIGURE 39 MONTERIS MEDICAL SWOT ANALYSIS

List of Tables

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)

TABLE 4 GLOBAL: EPILEPSY SURGERY MARKET, BY RESECTIVE SURGERY, 2018–2027 (USD MILLION)

TABLE 5 GLOBAL: EPILEPSY SURGERY MARKET, BY LASER INTERSTITIAL THERMAL THERAPY (LITT), 2018–2027 (USD MILLION)

TABLE 6 GLOBAL: EPILEPSY SURGERY MARKET, BY OTHERS, 2018–2027 (USD MILLION)

TABLE 7 GLOBAL: EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 8 GLOBAL: EPILEPSY SURGERY MARKET, BY HOSPITALS & CLINICS, 2018–2027 (USD MILLION)

TABLE 9 GLOBAL: EPILEPSY SURGERY MARKET, BY SPECIALTY CENTERS, 2018–2027 (USD MILLION)

TABLE 10 GLOBAL: EPILEPSY SURGERY MARKET, BY OTHERS, 2018–2027 (USD MILLION)

TABLE 11 GLOBAL: EPILEPSY SURGERY MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 12 AMERICAS EPILEPSY SURGERY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 AMERICAS EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)

TABLE 14 AMERICAS EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 15 NORTH AMERICA EPILEPSY SURGERY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 16 NORTH AMERICA EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)

TABLE 17 NORTH AMERICA EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 18 US EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)

TABLE 19 US EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 20 CANADA EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)

TABLE 21 CANADA EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 22 LATIN AMERICA EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)

TABLE 23 LATIN AMERICA EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 24 EUROPE EPILEPSY SURGERY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 EUROPE EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)

TABLE 26 EUROPE EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 27 WESTERN EUROPE EPILEPSY SURGERY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 28 WESTERN EUROPE EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)

TABLE 29 AMERICAS EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 30 GERMANY EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)

TABLE 31 GERMANY EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 32 UK EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)

TABLE 33 UK EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 34 FRANCE EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)

TABLE 35 FRANCE EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 36 ITALY EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)

TABLE 37 ITALY EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 38 SPAIN EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)

TABLE 39 SPAIN EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 40 REST OF WESTERN EUROPE EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)

TABLE 41 REST OF WESTERN EUROPE EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 42 EASTERN EUROPE EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)

TABLE 43 EASTERN EUROPE EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 44 ASIA PACIFIC: EPILEPSY SURGERY MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 45 ASIA-PACIFIC: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION)

TABLE 46 ASIA-PACIFIC: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 47 CHINA: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION)

TABLE 48 CHINA: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 49 JAPAN: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION)

TABLE 50 JAPAN: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 51 INDIA: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION)

TABLE 52 INDIA: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 53 SOUTH KOREA: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION)

TABLE 54 SOUTH KOREA: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 55 AUSTRALIA: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION)

TABLE 56 AUSTRALIA: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 57 REST OF ASIA PACIFIC: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION)

TABLE 58 REST OF ASIA PACIFIC: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 59 MIDDLE EAST & AFRICA: EPILEPSY SURGERY MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 60 MIDDLE EAST & AFRICA: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION)

TABLE 61 MIDDLE EAST & AFRICA: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 62 MIDDLE EAST: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION)

TABLE 63 MIDDLE EAST: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 64 AFRICA: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION)

TABLE 65 AFRICA: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 66 MAJOR PLAYERS IN THE GLOBAL EPILEPSY SURGERY MARKET

TABLE 67 MOST ACTIVE PLAYER IN THE GLOBAL EPILEPSY SURGERY MARKET

TABLE 68 PRODUCT LAUNCH/PRODUCT APPROVAL

TABLE 69 MERGER/ACQUISITION

TABLE 70 STRYKER: PRODUCTS/SERVICES OFFERED

TABLE 71 ZIMMER BIOMET HOLDINGS INC.: PRODUCTS/SERVICES OFFERED

TABLE 72 ZIMMER BIOMET HOLDINGS INC: KEY DEVELOPMENTS

TABLE 73 AURIS HEALTH, INC. (HANSEN MEDICAL, INC.): PRODUCTS/SERVICES OFFERED

TABLE 74 AURIS HEALTH, INC. (HANSEN MEDICAL, INC.): KEY DEVELOPMENTS

TABLE 75 INTUITIVE SURGICAL: PRODUCTS/SERVICES OFFERED

TABLE 76 INTUITIVE SURGICAL: KEY DEVELOPMENTS

TABLE 77 MEDTRONIC PLC: PRODUCTS/SERVICES OFFERED

TABLE 78 MEDTRONIC PLC: KEY DEVELOPMENTS

TABLE 79 CEPHALON, INC.: PRODUCTS/SERVICES OFFERED

TABLE 80 CMR SURGICAL: PRODUCTS/SERVICES OFFERED

TABLE 81 CMR SURGICAL: KEY DEVELOPMENTS

TABLE 82 NATUS MEDICAL INCORPORATED: PRODUCTS OFFERED

TABLE 83 LIVANOVA PLC: PRODUCTS OFFERED

TABLE 84 MONTERIS MEDICAL: PRODUCTS/SERVICES OFFERED

TABLE 85 MONTERIS MEDICAL: KEY DEVELOPMENTS